The Association between Leptin Level and Breast Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Niu, Jingping ^a   Jiang, Le ^a   Guo, Weiheng ^a   Shao, Liang ^b   Liu, Yi ^a   Wang, Liqin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Zhuhai Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; CONFIDENCE INTERVAL; DATA BASE; HORMONE BLOOD LEVEL; HUMAN; LYMPH NODE METASTASIS; MEDLINE; META ANALYSIS (TOPIC); POSTMENOPAUSE; PREMENOPAUSE; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; FEMALE; META ANALYSIS; PROGNOSIS;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEPTIN; LYMPHATIC METASTASIS; PROGNOSIS;

EID: 84879508393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067349     Document Type: Article

References (46)

1. Ray A, (2012) Adipokine leptin in obesity-related pathology of breast cancer. J Biosci 37: 289-294.
2. Amir E, Freedman OC, Seruga B, Evans DG, (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102: 680-691.
3. McKenna MC, Zevon MA, Corn B, Rounds J, (1999) Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18: 520-531.
4. Sestak I, Harvie M, Howell A, Forbes JF, Dowsett M, et al. (2012) Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer. Breast Cancer Res Treat.
5. Markowska A, Malendowicz K, Drews K, (2004) The role of leptin in breast cancer. Eur J Gynaecol Oncol 25: 192-194.
6. JardeT, Perrier SM, Vasson P, Caldefie-Chezet F, (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47: 33-43.
7. Liu C, Liu L, (2011) Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis. Tumour Biol 32: 1233-1240.
8. He BS, Pan YQ, Zhang Y, Xu YQ, Wang SK, (2012) Effect of LEPR Gln223Arg polymorphism on breast cancer risk in different ethnic populations: a meta-analysis. Mol Biol Rep 39: 3117-3122.
9. Wang LQ, Shen W, Xu L, Chen MB, Gong T, et al. (2012) The association between polymerphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis. Breast Cancer Res Treat 136: 231-239.
10. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
11. Higgins J, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557.
12. Harbord R, Higgins J (2009) Metareg: Stata module to perform meta-analysis regression. Statistical Software Components.
13. Sharp S (1998) Meta-analysis regression. Stata Technical Bulletin 7.
14. Sterne JA, Egger M, (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54: 1046-1055.
15. Mai Jz, Li H, Fang Jq, Liu Xq, Yao Yy, (2006) Estimation of Fail-Safe Number in Meta-Analysis The Journal of Evidence-Based Medicine. 05: 297-300-303.
16. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, et al. (2004) Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89: 1102-1107.
17. Tessitore L, Vizio B, Pesola D, Cecchini F, Mussa A, et al. (2004) Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 24: 1529-1535.
18. Jen KL, Buison A, Darga L, Nelson D, (2005) The relationship between blood leptin level and bone density is specific to ethnicity and menopausal status. J Lab Clin Med 146: 18-24.
19. Wang XM, Hao LH, Sun DM, (2005) Clinical Significance of Detection of Serum Leptin, Insulin-Like Growth Factor-1 and Tumor Necrosis Factorαin Breast Cancer Patient. Acta Acad Med Weifang 03: 188-189.
20. Gao JX, Zhang JY, Dong QY, (2005) Clinical significance of detection of serum leptin, insulin-like growth factor-1 and tumor necrosis factor α in breast cancer patient. Laboratory Medicine 01: 28-29.
21. Chen DC, Chung YF, Yeh YT, Chaung HC, Kuo FC, et al. (2006) Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237: 109-14.
22. Jiang DL, Chen J, Sun JM, Xue M, Hu BN, et al. (2006) Serum Leptin and Soluble Leptin Receptor (sLR) Levels in Patients with Breas tCarcinoma. J of Radioimmunology 05: 382-383.
23. Liu CL, Chang YC, Cheng SP, Chern SR, Yang TL, et al. (2007) The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 72: 75-81.
24. Han CZ, Du LL, Jing JX, Zhao XW, Tian FG, et al. (2008) Associations among lipids, leptin, and leptin receptor gene Gin223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res 126: 38-48.
25. Aliustaoglu M, Bilici A, Gumus M, Colak AT, Baloglu G, et al. (2010) Preoperative serum leptin levels in patients with breast cancer. Med Oncol 27: 388-391.
26. Cui HX (2009) Association among adiponectin, adiponectin gene polymophisms with risk of breast cancer. Shanxi Medical University.
27. Fan XL (2009) The study of mammographic density, serum levels of leptin and so forth correlative factors in breast cancer. Shanxi Medical University.
28. Liu Y, Xue H, Deng ZH, Yan GT, (2010) The Clinical Significance of Defermination of serum Leptin, C-reactive protein and Alpha 1-antitrypsin Levels in Patients with Breast Cancer. vJ of Radioimmunology 03: 243-245.
29. Wang Y (2011) An associativity study of expressions of leptin and leptin receptor with breast cancer. Shanxi Medical University.
30. Du LL, Han CZ, Liu XY, Jing JX, Zhao XW, et al. (2006) Relationship between serum leptin level BMI and breast cancer incidence. Cancer Research and Clinic 05: 307-309.
31. Woo HY, Park H, Ki CS, Park YL, Bae WG, (2006) Relationships among serum leptin, leptin receptor gene polymorphisms, and breast cancer in Korea. Cancer Lett 237: 137-142.
32. Maccio A, Madeddu C, Gramignano G, Mulas C, Floris C, et al. (2010) Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. J Mol Med (Berl) 88: 677-686.
33. Yu H, Zhu WR, Xu SH, (2005) Clinical Significance of Determination of Leptin Levels in Patients with Breast Cancer. J of Radioimmunology 05: 327-329.
34. Huang XD, (2006) Determination of Serum Leptin and Vascular Endothelial Growth Factor (VEGF) Contents in Patients with Breast Cancer. J of Radioimmunology 19: 267-269.
35. Sun JM, Jiang Dl, (2006) Clinical significance of serum leptin,soluble leptin receptor and estradiol in breast cancer patients. Chin J Nccl Med 06: 360-362.
36. Dalamaga M, Karmaniolas K, Papadavid E, Pelekanos N, Sotiropoulos G, et al. (2011) Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters. Menopause 18: 1198-1204.
37. Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Kaprara A, Blakeman J, et al. (2007) Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer. Eur J Endocrinol 156: 187-194.
38. Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM, (2010) Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat 119: 367-367.
39. Harris HR, Tworoger SS, Hankinson SE, Rosner BA, Michels KB, (2011) Plasma leptin levels and risk of breast cancer in premenopausal women. Cancer Prev Res (Phila) 4: 1449-1456.
40. Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, et al. (2009) The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 113: 567-576.
41. Given GF, Smith DD, Tweedie RL, (1997) Pulication bias in meta analysis:a Bayesian data-augmentation approach for issues exemplified in the passive smoking debate. Stat Sci 12: 221-250.
42. Ishikawa M, Kitayama J, Nagawa H, (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10: 4325-4331.
43. Garofalo C, Sisci D, Surmacz E, (2004) Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10: 6466-6475.
44. Otvos L Jr, Kovalszky I, Riolfi M, Ferla R, Olah J, et al. (2011) Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur J Cancer 47: 1578-1584.
45. Grossmann ME, Ray A, Dogan S, Mizuno NK, Cleary MP, (2012) Balance of adiponectin and leptin modulates breast cancer cell growth Biochimie. 94: 2164-2171.
46. Rose DP, Gilhooly EM, Nixon DW, (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 21: 1285-1292.